Reference:
1. European medicines Agency. Scientific Conclusion and Grounds for Amendment of the Summaries of Product Characteristics, Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Augmentin_30/ WC500154630.pdf
2. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics 2013;131:e964-99.
3. Clavulanic acid [Internet]. Massachusetts: E-DRUG. Available from: http://www.essentialdrugs.org/edrug/archive/200209/msg00024.php
Keywords:
-